Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838667 · ClinicalTrials.gov registry record · NA
Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,300
- Enrollment target
NCT02838667: Completed NA study, sponsored by Mayo Clinic.
NCT02838667 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02838667, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,300 participants
- Enrollment target
Study Summary
Nephrology participation in care of patients undergoing CABG could reduce AKI through correction of modifiable risk factors and early detection and intervention of post-op AKI.
Interventions
- PROCEDURE Standard of Care plus Nephrology Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,300 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2019-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02838667
The ClinicalTrials.gov registry entry for NCT02838667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care plus Nephrology Care is the first listed.
NCT02838667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02838667 about?
NCT02838667 is a clinical study titled "Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)". Nephrology participation in care of patients undergoing CABG could reduce AKI through correction of modifiable risk factors and early detection and intervention of post-op AKI.
What is the current status of trial NCT02838667?
This trial is currently completed. It is a NA study. The enrollment target is 2,300 participants. The study started on 2016-07-01. Estimated completion is 2019-06-10.
What interventions are being tested in trial NCT02838667?
The interventions under investigation include: Standard of Care plus Nephrology Care (PROCEDURE).
Who is sponsoring clinical trial NCT02838667?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.